{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-081531","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2024-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.456965+00:00","generated_at":"2026-05-31T01:52:45.314952+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Unicycive Therapeutics regains compliance with Nasdaq minimum market value requirement","bullets":["Nasdaq confirmed compliance with Listing Rule 5550(b)(2) on Sept 24, 2024 after market value exceeded $35M for 10 consecutive days.","Market value was above $35M from Sept 10 to Sept 23, 2024, regaining compliance.","Company had previously received a non-compliance notice on July 11, 2024 for failing to meet the minimum market value.","Removes immediate risk of delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-081531","json":"https://secwatch.observer/filing/0001213900-24-081531.json","markdown":"https://secwatch.observer/filing/0001213900-24-081531.md","text":"https://secwatch.observer/filing/0001213900-24-081531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390024081531/0001213900-24-081531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390024081531/ea0215583-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:52:45.314952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}